Sequoia Financial Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-42,907
| Closed | -$37K | – | 392 |
|
|
2020
Q2 | $37K | Sell |
42,907
-25,814
| -38% | -$22.3K | ﹤0.01% | 364 |
|
|
2020
Q1 | $57K | Hold |
68,721
| – | – | ﹤0.01% | 355 |
|
|
2019
Q4 | $61K | Buy |
+68,721
| New | +$61K | ﹤0.01% | 375 |
|
|
2019
Q3 | – | Sell |
-68,721
| Closed | -$76K | – | 374 |
|
|
2019
Q2 | $76K | Sell |
68,721
-14
| -0% | -$15 | 0.01% | 366 |
|
|
2019
Q1 | $90K | Buy |
68,735
+35
| +0.1% | +$46 | 0.01% | 359 |
|
|
2018
Q4 | $63K | Sell |
68,700
-14,110
| -17% | -$12.9K | 0.01% | 287 |
|
|
2018
Q3 | $170K | Buy |
82,810
+33,775
| +69% | +$69.3K | 0.02% | 303 |
|
|
2018
Q2 | $88K | Sell |
49,035
-6,953
| -12% | -$12.5K | 0.01% | 298 |
|
|
2018
Q1 | $132K | Hold |
55,988
| – | – | 0.01% | 294 |
|
|
2017
Q4 | $105K | Hold |
55,988
| – | – | 0.01% | 296 |
|
|
2017
Q3 | $139K | Hold |
55,988
| – | – | 0.02% | 275 |
|
|
2017
Q2 | $154K | Hold |
55,988
| – | – | 0.02% | 270 |
|
|
2017
Q1 | $169K | Hold |
55,988
| – | – | 0.02% | 271 |
|
|
2016
Q4 | $177K | Hold |
55,988
| – | – | 0.03% | 259 |
|
|
2016
Q3 | $191K | Hold |
55,988
| – | – | 0.04% | 229 |
|
|
2016
Q2 | $128K | Sell |
55,988
-641
| -1% | -$1.47K | 0.04% | 239 |
|
|
2016
Q1 | $142K | Buy |
56,629
+997
| +2% | +$2.5K | 0.05% | 187 |
|
|
2015
Q4 | $184K | Hold |
55,632
| – | – | 0.07% | 165 |
|
|
2015
Q3 | $135K | Buy |
+55,632
| New | +$135K | 0.06% | 166 |
|